LSCCB strives to bring innovation to society with close collaboration with local, national, and international pharmaceutical and biotechnology companies and/or venture capitals with goals from generating patentable technological know-hows to drug leads, and novel molecular probes to product commercialization for therapeutic and diagnostic applications.
Chemmino Biotechnology Limited
Chemmino dedicates to developing and utilizing a range of novel illuminating materials to design, develop, and manufacture a series of miniature yet affordable diagnostic devices for point-of-care and even consumer level biomedical analyses.
GoldPorp Pharma Limited
GoldPorp Pharma dedicates to the discovery and clinical development of novel drugs for the treatment of advanced cancer. We envision a world where advanced cancer is just a treatable chronic disease. We have developed proprietary anticancer compounds that provide much better efficacy than commonly used platinum-based cancer drugs for treatment of advanced metastasized cancer and potentially replace existing chemotherapy.
L'Ord'invent Limited aims at inventing, devising, and refining rapid tools for diagnosing early cancer and prediction of cancer onset, treatment response and relapse. Also aims to transform rapid tools from hospital/laboratory tests to point-of-care and home self-monitoring tests.